The dermatology space continues to strive in therapeutic innovation; driven by a transformative evolution in the understanding of the pathophysiology of skin diseases and the availability of treatment options for conditions that affect the lives of millions of patients worldwide. This vast environment of opportunity is driving leading organisations and experts to focus on innovating and bringing better and more efficient therapies to market.

Expanding on two editions of the annual US meeting, the Dermatology Drug Development series makes its debut in Frankfurt to provide the European dermatology community with an end-to-end industry forum dedicated to bringing new dermatological medicines to market.

Join this growing platform to gain exclusive insights from experts, collaboratively tackle challenges being faced to develop these drugs and uncover the details behind the latest developments in this space.